The Nordic life sciences sector — pharma, medtech, digital health, biotech — is one of Europe's most internationally active M&A markets. Your network in this community has global deal value that a platform like ONEtoONE can convert into mandates.
ONEtoONE is a global network of 120+ independent M&A advisors in 55 countries. We are expanding our Senior Industry Advisor community in the Nordic healthcare market — connecting former sector executives with institutional M&A infrastructure and a global counterpart network.
What you get
- Competitive revenue share on mandates you originate or where your expertise is the deal differentiator
- Active Nordic healthcare deal flow: pharma, medtech, digital health, biotech, diagnostics, healthcare services
- Institutional brand: operate as a Senior Advisor of a recognised global investment banking platform
- 200+ advisors in 55 countries — connecting Nordic life sciences companies with European and global strategic buyers
- Zero execution overhead: dedicated analyst team, sector databases, pitch materials fully provided
Who you are
- Former CEO, MD, CMO, or CFO of a Nordic pharma, medtech, or life sciences company — 20+ years in the sector
- Deep personal network within the Swedish, Finnish, Norwegian, or Danish healthcare and investment community
- Familiarity with M&A, partnerships, licensing, or capital raises from the operator's perspective
- Currently independent, board-active, or exploring a portfolio career
Nordic life sciences companies are increasingly sought-after targets and cross-border acquirers. ONEtoONE Senior Industry Advisors are positioned at exactly that intersection.